Viewing Study NCT00291057


Ignite Creation Date: 2025-12-24 @ 6:35 PM
Ignite Modification Date: 2026-01-04 @ 4:37 AM
Study NCT ID: NCT00291057
Status: TERMINATED
Last Update Posted: 2013-12-23
First Post: 2006-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
Sponsor: Sun Pharmaceutical Industries, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MALG-0508
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Medical Director
Old Organization: Taro Pharmaceuticals USA

Collaborators